BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34080686)

  • 21. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
    Naumann M; Lowe NJ
    BMJ; 2001 Sep; 323(7313):596-9. PubMed ID: 11557704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Botulinum toxin in the treatment of focal hyperhidrosis].
    Schnider P; Moraru E; Kittler H; Voller B; Kranz G; Auff E
    Wien Klin Wochenschr; 2001; 113 Suppl 4():36-41. PubMed ID: 15506051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence-based medicine: botulinum toxin in focal hyperhidrosis.
    Naumann M
    J Neurol; 2001 Apr; 248 Suppl 1():31-3. PubMed ID: 11357238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of botulinum toxin-a therapy for palmar hyperhidrosis in plantar sweat production.
    Gregoriou S; Rigopoulos D; Makris M; Liakou A; Agiosofitou E; Stefanaki C; Kontochristopoulos G
    Dermatol Surg; 2010 Apr; 36(4):496-8. PubMed ID: 20180837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Iyer S
    Dermatol Surg; 2002 Sep; 28(9):822-7. PubMed ID: 12269876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary focal hyperhidrosis: current treatment options and a step-by-step approach.
    Hoorens I; Ongenae K
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):1-8. PubMed ID: 21749468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect and persistency of botulinum toxin iontophoresis in the treatment of palmar hyperhidrosis.
    Davarian S; Kalantari KK; Rezasoltani A; Rahimi A
    Australas J Dermatol; 2008 May; 49(2):75-9. PubMed ID: 18412805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis.
    Rompel R; Scholz S
    J Eur Acad Dermatol Venereol; 2001 May; 15(3):207-11. PubMed ID: 11683282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperhidrosis treatments in hidradenitis suppurativa: A systematic review.
    Shih T; Lee K; Seivright JR; De DR; Shi VY; Hsiao JL
    Dermatol Ther; 2022 Jan; 35(1):e15210. PubMed ID: 34796606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis.
    Rummaneethorn P; Chalermchai T
    Lasers Med Sci; 2020 Jul; 35(5):1179-1184. PubMed ID: 31939036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperhidrosis Substantially Reduces Quality of Life in Children: A Retrospective Study Describing Symptoms, Consequences and Treatment with Botulinum Toxin.
    Mirkovic SE; Rystedt A; Balling M; Swartling C
    Acta Derm Venereol; 2018 Jan; 98(1):103-107. PubMed ID: 28761964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
    Lowe N; Campanati A; Bodokh I; Cliff S; Jaen P; Kreyden O; Naumann M; Offidani A; Vadoud J; Hamm H
    Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective analysis of the efficacy and duration of botulinum toxin A injections in 30 patients with palmar hyperhidrosis.
    Farrell J; Stewart T; Singh B; Singh G; Rosen R
    Intern Med J; 2021 Sep; 51(9):1517-1521. PubMed ID: 34541778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study.
    Campanati A; Penna L; Guzzo T; Menotta L; Silvestri B; Lagalla G; Gesuita R; Offidani A
    Clin Ther; 2003 Jan; 25(1):298-308. PubMed ID: 12637128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary hyperhidrosis: Implications on symptoms, daily life, health and alcohol consumption when treated with botulinum toxin.
    Shayesteh A; Boman J; Janlert U; Brulin C; Nylander E
    J Dermatol; 2016 Aug; 43(8):928-33. PubMed ID: 26875781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CT-Guided Chemical Thoracic Sympathectomy versus Botulinum Toxin Type A Injection for Palmar Hyperhidrosis.
    Yang H; Kang J; Zhang S; Peng K; Deng B; Cheng B
    Thorac Cardiovasc Surg; 2019 Aug; 67(5):402-406. PubMed ID: 30216949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Toxin treatment of sweat pearls. A review of the treatment of hyperhidrosis with a special view of a new therapy option using botulinum toxin A].
    Kreyden OP; Burg G
    Schweiz Med Wochenschr; 2000 Jul; 130(29-30):1084-90. PubMed ID: 10971942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of botulinum toxin type B for the treatment of primary palmar hyperhidrosis: a prospective, open, single-blind, multi-centre study.
    Basciani M; Di Rienzo F; Bizzarrini M; Zanchi M; Copetti M; Intiso D
    Arch Dermatol Res; 2014 Jul; 306(5):497-503. PubMed ID: 24522897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Palmar Hyperhidrosis with Tap Water Iontophoresis: A Randomized, Sham-Controlled, Single-Blind, and Parallel-Designed Clinical Trial.
    Kim DH; Kim TH; Lee SH; Lee AY
    Ann Dermatol; 2017 Dec; 29(6):728-734. PubMed ID: 29200761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
    Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.